For medicinal products and plant protection products, approval or official authorisation must be obtained (from Swissmedic, the Federal Veterinary Office or the Federal Office for Agriculture, for example) before they can be used commercially. This authorisation procedure can sometimes take up to ten years, during which time the term of protection for the associated patent is already running. Therefore, to compensate for this situation, it is possible to request a supplementary protection certificate (SPC). The term of protection of the SPC begins as soon as the maximum term of protection (20 years) of the patented active ingredient expires. An SPC extends protection for up to a further five years.
For an SPC to be granted, the following criteria must be fulfilled:
- SPCs can only be granted on the basis of a valid patent and official authorisation or approval.
An SPC must be requested within six months from:
- the first official authorisation or approval in Switzerland; or
- the grant of the patent if this is granted later than the first official authorisation or approval.
Extending protection for paediatric medicinal products
Anyone carrying out paediatric studies for patented medicinal products can extend patent protection by six months with an SPC, or – if no conventional SPC exists – request a "paediatric SPC", which is also valid for six months.
- Patent Examination Guidelines (in French)
- Form to request an SPC (in German)
- Form to request an SPC (in French)
- Form to request an SPC (in Italian)
- Change of practice for granting supplementary protection certificates (SPCs)
- Guidelines, Chapter 13.2.1 (in German)
- Case studies of guidelines 13.2.1 (in German)
- Swiss Patents Act (PatA)
- Patents Ordinance (PatV) in German
SMEs used the lockdown period to develop new ideas – an insight into an initiative of the IPI during the coronavirus crisis
08.06.2020 | Patents
More support for innovative SMEs and start-ups – assisted patent searches at a reduced fee until the end of 2020
Better international protection for Swiss geographical indications
The IPI is actively participating in the WIPO dialogue on intellectual property and artificial intelligence
08.11.2019 | Event
Symposium on Creative Approaches to Improving Access to Medicines Globally
Roundtable on the protection of computer-implemented inventions